All parameters including plaque index (PI), probing depth (PD), attachment loss (AL) and bleeding on probing (BOP) were measured at baseline, 4 and 7 weeks after treatment.
The following clinical parameters were measured at baseline, 2, 4, 6, 8, 10 and 12 weeks after treatment: plaque index (PI), bleeding on probing (BOP) and probing depth (PD).
